tofacitinib
pfizer
['tofacitinib', 'tofa']
year in review, oral survalience study of tofacitinib. increased risk of combined cardiovascular disease and cancer. number needed to harm is 16 if you treat a pt with prior ascvd #acr22 #acrambassador 
Tweeting anything #Rheum #COVID-19
MD | PhD | Rheumatology #RheumTwitter